Mutation of TP53, translocation analysis and immunohistochemical expression of MYC, BCL-2 and BCL-6 in patients with DLBCL treated with R-CHOP
Pekka Peroja(Oulu University Hospital), Outi Kuittinen(University of Eastern Finland), Taina Turpeenniemi‐Hujanen(Oulu University Hospital), Kaija Vasala(Central Finland Health Care District), Jan Böhm(Central Finland Health Care District), Jenni Peltonen(Oulu University Hospital), Peeter Karihtala(University of Helsinki), Mette Ølgod Pedersen(University of Copenhagen), Tuomo Mantere(Oulu University Hospital), Peter Nørgaard(Rigshospitalet), Kirsi‐Maria Haapasaari(University of Oulu), Katrin Rapakko(University of Oulu), Esa Jantunen(University of Eastern Finland), Ylermi Soini(Kuopio University Hospital)
Cited by 31
Related Papers
Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer
|New England Journal of Medicine|2006|1.4k
Long-Read Sequencing Emerging in Medical Genetics
|Frontiers in Genetics|2019|465
A recurrent mutation in PALB2 in Finnish cancer families
|Nature|2007|461